Author: Paul Govern
Jan. 26, 2022—A smartphone app developed at Vanderbilt is assisting health care efforts in low- and middle-income countries.
Jan. 20, 2022—Researchers at Vanderbilt University Medical Center have developed a new method for identifying drugs for the repurposing trials that can lead to new indications for drugs already in use.
Jan. 13, 2022—Vanderbilt’s Master of Science in Applied Clinical Informatics program is now accepting applications for fall 2022.
Jan. 3, 2022—Jennifer Green, MD, MPH, assistant professor of Medicine, and surgeon Marc Bennett, MD, MMHC, professor of Otolaryngology — Head and Neck Surgery, have been appointed co-executive medical directors for patient safety for Vanderbilt University Hospital (VUH) and Clinics.
Jan. 3, 2022—Karen Bloch, MD, MPH, and David Haas, MD, have been appointed interim leaders of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center.
Dec. 16, 2021—Vanderbilt research is blazing a trail for the application of game theory to genomic and health data reidentification risk.
Dec. 16, 2021—Nicole Ward, PhD, has joined Vanderbilt as professor and vice-chair of Basic Research in the Department of Dermatology, effective Jan. 15, 2021.
Dec. 1, 2021—A study by Vanderbilt researchers sheds light on how current antidepressant drugs work and suggests a new drug target in depression.
Nov. 19, 2021—Vanderbilt researchers took part in an online panel discussion this week sponsored by the Women’s Alzheimer’s Movement (WAM), hosted by journalist and author Maria Shriver, the organization’s founder, and NBC news anchor Richard Lui.
Nov. 17, 2021—Vanderbilt University Medical Center has received $550,000 from the Doris Duke Charitable Foundation’s (DDCF) COVID-19 Fund to Retain Clinical Scientists.